PRQR
Price
$2.05
Change
+$0.03 (+1.49%)
Updated
Aug 15 closing price
Capitalization
215.96M
81 days until earnings call
WVE
Price
$9.78
Change
+$0.86 (+9.65%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
1.55B
82 days until earnings call
Interact to see
Advertisement

PRQR vs WVE

Header iconPRQR vs WVE Comparison
Open Charts PRQR vs WVEBanner chart's image
ProQR Therapeutics
Price$2.05
Change+$0.03 (+1.49%)
Volume$124.83K
Capitalization215.96M
Wave Life Sciences
Price$9.78
Change+$0.86 (+9.65%)
Volume$61.73K
Capitalization1.55B
PRQR vs WVE Comparison Chart in %
Loading...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRQR vs. WVE commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRQR is a Hold and WVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (PRQR: $2.05 vs. WVE: $9.76)
Brand notoriety: PRQR and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRQR: 43% vs. WVE: 195%
Market capitalization -- PRQR: $215.96M vs. WVE: $1.55B
PRQR [@Biotechnology] is valued at $215.96M. WVE’s [@Biotechnology] market capitalization is $1.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRQR’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • PRQR’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, both PRQR and WVE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRQR’s TA Score shows that 3 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).

  • PRQR’s TA Score: 3 bullish, 7 bearish.
  • WVE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, WVE is a better buy in the short-term than PRQR.

Price Growth

PRQR (@Biotechnology) experienced а -5.53% price change this week, while WVE (@Biotechnology) price change was +20.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

PRQR is expected to report earnings on Nov 05, 2025.

WVE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.55B) has a higher market cap than PRQR($216M). WVE YTD gains are higher at: -21.099 vs. PRQR (-22.642). PRQR has higher annual earnings (EBITDA): -26.88M vs. WVE (-134.84M). WVE has more cash in the bank: 208M vs. PRQR (132M). PRQR has less debt than WVE: PRQR (16.9M) vs WVE (21.7M). WVE has higher revenues than PRQR: WVE (93.9M) vs PRQR (19M).
PRQRWVEPRQR / WVE
Capitalization216M1.55B14%
EBITDA-26.88M-134.84M20%
Gain YTD-22.642-21.099107%
P/E RatioN/AN/A-
Revenue19M93.9M20%
Total Cash132M208M63%
Total Debt16.9M21.7M78%
FUNDAMENTALS RATINGS
PRQR vs WVE: Fundamental Ratings
PRQR
WVE
OUTLOOK RATING
1..100
6882
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6142
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (34) in the Biotechnology industry is in the same range as WVE (63). This means that PRQR’s stock grew similarly to WVE’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as WVE (100). This means that PRQR’s stock grew similarly to WVE’s over the last 12 months.

PRQR's SMR Rating (96) in the Biotechnology industry is in the same range as WVE (100). This means that PRQR’s stock grew similarly to WVE’s over the last 12 months.

WVE's Price Growth Rating (42) in the Biotechnology industry is in the same range as PRQR (61). This means that WVE’s stock grew similarly to PRQR’s over the last 12 months.

WVE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that WVE’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRQRWVE
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGASX18.510.04
+0.22%
Baillie Gifford Global Alpha Equities I
GMRAX12.11N/A
N/A
Nationwide Small Cap Index A
LAVYX16.55N/A
N/A
Lord Abbett Fundamental Equity I
GCAVX21.84N/A
N/A
GMO US Small Cap Value VI
MEMJX42.35-0.10
-0.24%
MFS Emerging Markets Equity R6

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with WVE. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
+1.49%
WVE - PRQR
61%
Loosely correlated
+9.54%
KRRO - PRQR
58%
Loosely correlated
+1.91%
ATNF - PRQR
46%
Loosely correlated
-7.49%
ENVB - PRQR
43%
Loosely correlated
-0.90%
OCUL - PRQR
35%
Loosely correlated
-0.24%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+9.54%
PRQR - WVE
60%
Loosely correlated
+1.49%
KRRO - WVE
53%
Loosely correlated
+1.91%
OCUL - WVE
47%
Loosely correlated
-0.24%
KYMR - WVE
45%
Loosely correlated
+2.60%
NRIX - WVE
40%
Loosely correlated
+0.19%
More